| Product Name | Hydroxy Darunavir |
| Product Code | DA-D035-25 |
| Chemical name | N-[3-[[(4-aminophenyl)sulfonyl](2-hydroxy-2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic Acid Hexahydrofuro[2,3-b]furan-3-yl Ester |
| Synonyms | (3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-((4-amino-N-(2-hydroxy-2-methylpropyl)phenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate; |
| Impurity | NA |
| CAS Number | 1130635-75-4 |
| Alternate CAS # | NA |
| Molecular form | C27H37N3O8S |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 563.67 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | impurities,metabolites,pharmaceutical standards,intermediates,fine chemicals |
| Boiling Point | NA |
| Applications | A metabolite of Daranavir. It is a COVID19-related research product. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
